Collagen
Collagen is the most common structural protein in the body; human studies show benefits for joints, skin, tendons and muscles.
We evaluated 235 human studies on Collagen, including 122 randomised controlled trials and 30 meta-analyses or systematic reviews; the controlled studies include 7,680 participants in total. As of 4 October 2026.
1. What Is Collagen? Occurrence, Origin and Forms
Collagen is a structural protein and the most abundant protein in the human body. It forms the scaffold of skin, tendons, ligaments, cartilage, bone and blood vessels. Traditionally it is taken in through gelatin-containing foods such as bone broths and aspics, and today also through collagen preparations.
Collagen occurs in the connective tissue of humans and animals, especially in skin, tendons, cartilage and bone. For preparations it is obtained from animal hides, bones and cartilage as well as from fish skin and fish scales.
The starting material is animal collagen, which is processed into gelatin by heating or into shorter collagen peptides by enzymatic cleavage. Studies mainly examine orally taken collagen peptides, gelatin and undenatured type II collagen from cartilage.
Forms and Preparations Studied
- Collagen peptides (hydrolysed collagen)
- Gelatin
- Undenatured type II collagen
- Collagen-containing foods such as bone broth
- Collagen in skin creams and other topical preparations
Not covered on this page:
- Elastin
- Hyaluronic acid
- Whey protein
- Creatine
2. What Does Collagen Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Joints and joint pain | mostly improved | high | 11 meta-analyses · 40 controlled · 23 other | 3,432 |
| Skin and skin elasticity | mostly improved | high | 8 meta-analyses · 32 controlled · 26 other | 2,042 |
| Musculature | mixed | high | 5 meta-analyses · 32 controlled · 9 other | 1,343 |
| Bone density | mixed | high | 3 meta-analyses · 12 controlled · 9 other | 797 |
| Tendons and ligaments | mostly improved | high | 3 meta-analyses · 9 controlled · 5 other | 291 |
| Hair and nails | mostly improved | moderate | 0 meta-analyses · 3 controlled · 5 other | 125 |
| Other investigations | mostly improved | high | 6 meta-analyses · 56 controlled · 28 other | 2,596 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Collagen, Joints and Joint Pain: Human Studies
In joint pain and knee osteoarthritis, several controlled studies and meta-analyses showed improvements in pain and function with oral collagen peptides (hydrolyzed collagen) 69313458. Non-denatured type II collagen improved knee mobility compared with placebo in three randomized controlled studies 537386. Individual studies examined combination preparations, such as a liquid nutraceutical with hydrolyzed fish collagen, chondroitin sulfate, glucosamine and other substances 42, or a collagen hydrolysate with minerals and vitamins 54; these findings cannot be attributed to collagen alone. The overall reliability is high, but many studies were small and short, and information on manufacturer funding is missing for several preparations.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ravindran et al. 2026 | systematic review · 7,983 participants | collagen supplements (form not specified); vs. placebo/control (not reported) | osteoarthritis: improved |
| 3 Zahed et al. 2025 | systematic review · 1,264 participants | Collagen meniscus implant, matrix-based meniscus repair, oral collagen supplementation; Follow-up up to 10 years; vs. Comparison of the three collagen interventions with each other | Lysholm score after collagen meniscus implant: improved (80 to 95); Subjective IKDC score after collagen meniscus implant: improved (77-95); Partial resorption on MRI after collagen meniscus implant: worsened (79%-92% of cases) |
| 6 Simental-Mendía et al. 2025 | meta-analysis · 870 participants | Oral collagen supplements (form not specified); vs. Placebo | Function score: improved (MD, -6.46 (95% CI -9.52, -3.40); I2=75%; p=0.00001); Pain score: improved (MD, -13.63 (95% CI -20.67, -6.58); I2=88%; p=0.00001) |
| 9 Lin et al. 2023 | meta-analysis · 507 participants | Collagen peptides or hydrolyzed collagen; vs. Placebo | Pain relief: improved (SMD: -0.58; 95% CI -0.98, -0.18, p = 0.004) |
| 17 Gupta et al. 2025 | systematic review | Undenatured type II collagen (UC-2); 40 mg daily; short- and mid-term (exact duration not reported); vs. no comparator; review of preclinical and clinical studies | inflammation and pain: improved; function and range of motion (ROM): improved |
| 18 Brueckheimer et al. 2025 | systematic review | Oral type I hydrolyzed collagen; vs. Control groups of included RCTs | Pain reduction and clinical parameters: improved; Physical mobility and ankle function: improved |
| 24 Jabbari et al. 2022 | systematic review | Collagen supplementation: intact, hydrolyzed and type II collagen; vs. routine treatments or controls | efficacy in OA and RA: unclear; adverse effects of collagen supplementation |
| 25 Khatri et al. 2021 | systematic review | Collagen peptide supplementation (COL), partly combined with exercise; 15 g/day COL (reported for collagen synthesis); vs. Usual care/control or isonitrogenous higher quality protein | Joint functionality and joint pain: improved |
Further studies in this area: 26 28 29 30 31 32 33 34 35 36 37 38 39 40 42 46 48 53 54 58 59 63 65 68 70 73 75 76 86 91 93 105 107 111 113 127 144 149 150 152 153 158 166 167 172 173 175 176 177 178 204 212 214 215 219 220 221 223 224 226 227 228 230 231 232 233
Collagen, Skin and Skin Elasticity: Human Studies
For skin and skin elasticity, several controlled studies and meta-analyses showed improvements in skin elasticity after oral collagen peptides (hydrolyzed collagen) 24571343. Skin moisture also improved in several controlled studies and meta-analyses with collagen peptides 245134344. For wrinkles, a series of randomized controlled studies with collagen peptides found an improvement 41323434749. Skin roughness and dermal density improved more with collagen peptides than with placebo in several randomized controlled studies 44475067. A systematic review and a randomized controlled study also report more collagen in the dermis 7110. In contrast, three randomized controlled studies found no difference from placebo in skin elasticity, skin thickness or skin moisture 515684. For skin firmness, hydrolyzed collagen was inferior to an eggshell membrane (MKARE®) in a randomized controlled study 145. Two randomized controlled studies tested combination preparations: with acerola fruit extract, vitamin C, zinc, biotin and vitamin E 66 and, funded by the manufacturer, with wheat germ oil, ceramides and lutein 77.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ravindran et al. 2026 | systematic review · 7,983 participants | collagen supplements (form not specified); vs. placebo/control (not reported) | skin elasticity and hydration: improved |
| 2 Pu et al. 2023 | meta-analysis · 1,721 participants | Hydrolyzed collagen (HC) supplementation; varying supplementation duration analyzed in subgroups; vs. placebo group | skin hydration: improved (Z = 4.94, p < 0.00001); skin elasticity: improved (Z = 4.49, p < 0.00001) |
| 4 de et al. 2021 | meta-analysis · 1,125 participants | Oral hydrolyzed collagen supplementation; 90 days; vs. Placebo | Skin hydration: improved; Skin elasticity: improved; Skin wrinkles: improved |
| 5 Dewi et al. 2023 | meta-analysis · 967 participants | Oral hydrolyzed collagen supplementation; 12 weeks; vs. Placebo | Skin moisture levels: improved; Skin elasticity: improved |
| 7 Choi et al. 2019 | systematic review · 805 participants | Oral collagen supplements: hydrolysate, tripeptide, dipeptide; Hydrolysate 2.5–10 g/d; tripeptide 3 g/d; 8–24 weeks (hydrolysate); 4–12 weeks (tripeptide); vs. Placebo | Skin elasticity and hydration: improved (notable improvement); Dermal collagen density: improved; Skin aging: improved |
| 10 Howell-Morris et al. 2020 | systematic review · 430 participants | Orally administered collagen peptides, one study combined with antioxidants; 570 mg/d to 10 g/d; 8 weeks to 6 months; vs. Randomised controlled trials, mostly with control measures for confounders | Dermal thickness: improved (significant improvement); Dermal collagen or pro-collagen content: improved (two of the studies showed improvement); Dermal elasticity: improved (three of the studies showed improvement) |
| 13 Bassila et al. 2026 | systematic review · 25 participants | Oral hydrolyzed collagen (HC); vs. Placebo or active comparators | Skin hydration: improved (improved in 10 of 15 trials); Skin elasticity: improved (10 of 13 trials); Wrinkle depth or volume: improved (9 of 10 trials) |
| 21 Rahman et al. 2024 | systematic review | marine collagen, partly enriched with amino acids | skin aging and skin health: improved |
Further studies in this area: 23 27 42 43 44 45 47 49 50 51 56 57 60 61 66 67 69 74 77 78 84 88 101 104 110 121 142 145 148 156 157 159 160 161 173 174 180 184 188 190 192 194 196 197 198 200 201 202 205 210 211 213 214 218 220 222 225 229
Collagen and Musculature: Human Studies
With strength training, fat-free mass increased more with collagen peptides than with placebo in a meta-analysis and several randomized controlled studies 852628187117. Muscle strength increased more than with placebo in two studies 6287, but not in three others 819297. Muscle soreness after exertion was lower than with placebo in one randomized controlled study 125, but not in another 85. Muscle protein synthesis did not increase more with collagen than with placebo 94116 and remained behind whey protein, yeast protein and α-lactalbumin 25133137. Muscle cross-section did not grow more with training under collagen than under placebo in three randomized controlled studies 8192112, but calf muscle thickness did in one study 97. Anabolic signaling pathways in muscle were more activated after strength training with collagen peptides than with placebo 151; a multi-component protein preparation increased type II muscle fibers more than collagen 162. The findings come predominantly from small, short studies in trained or older adults; some tested combination preparations with chicken essence 3839, vitamins and minerals 54 or whey protein 95.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ravindran et al. 2026 | systematic review · 7,983 participants | collagen supplements (form not specified); vs. placebo/control (not reported) | muscular health: improved |
| 8 Bischof et al. 2024 | meta-analysis · 768 participants | Collagen peptide supplements (hydrolyzed collagen); at least 8 weeks (one 3-week trial for maximal strength only; 1 week without exercise for recovery); vs. Control group (RCTs) | Fat-free mass: improved (SMD 0.48, p < 0.01); Muscle architecture: improved (SMD 0.39, p < 0.01); Maximal strength: improved (SMD 0.19, p < 0.01) |
| 11 Inacio et al. 2024 | systematic review · 286 participants | Collagen peptides or hydrolyzed collagen, low molecular weight (2000-3500 daltons); vs. Placebo or control | Muscle stress after acute strenuous resistance training: improved |
| 12 Buchalski et al. 2026 | systematic review · 257 participants | Collagen supplementation, type not specified; 5-30 g/day, some with vitamin C ≥50 mg; 3-15 weeks, combined with resistance/plyometric training; vs. Placebo | Muscle strength: no difference (no additive effects of collagen); Muscle cross-sectional area: unclear (GRADE C) |
| 18 Brueckheimer et al. 2025 | systematic review | Oral type I hydrolyzed collagen; vs. Control groups of included RCTs | Muscle health: unclear |
| 19 Sun et al. 2025 | meta-analysis | Collagen peptides, partly with vitamin D and calcium; vs. Control groups without collagen peptides | Muscle performance: improved (SMD 0.60 [0.05, 1.15]) |
| 25 Khatri et al. 2021 | systematic review | Collagen peptide supplementation (COL), partly combined with exercise; 15 g/day COL (reported for collagen synthesis); vs. Usual care/control or isonitrogenous higher quality protein | Muscle protein synthesis (MPS): no difference |
| 38 Chen et al. 2023 | randomised controlled · 160 participants | Hydrolyzed type II collagen (HC-II) or chicken essence with added HC-II (EC-HC-II); 24 weeks; vs. Glucosamine HCl and placebo, all with resistance training | Fat-free mass at 24 weeks (EC-HC-II vs. placebo/glucosamine): improved (p = 0.02); Grip strength at 24 weeks (EC-HC-II vs. glucosamine): improved (p = 0.002) |
Further studies in this area: 39 52 54 62 80 81 85 87 92 94 95 97 105 112 114 115 116 117 119 120 122 125 126 128 133 137 141 143 151 162 164 181 206 208 209 214 223 224
Collagen and Bone Density: Human Studies
A meta-analysis found higher bone density at the femoral neck and spine with collagen peptides, especially together with calcium and vitamin D 19. In a randomized controlled trial in postmenopausal women with osteopenia, collagen peptides in addition to calcium and vitamin D improved bone density and bone turnover more than calcium and vitamin D alone 8990. In premenopausal female endurance runners, a bone formation marker increased with collagen peptides, but not in the control group 118. A calcium-collagen chelate slowed the loss of whole-body bone density in postmenopausal women with osteopenia more than calcium and vitamin D alone 102. In contrast, a randomized controlled trial in older adults after total hip replacement found no differences in bone formation and bone resorption markers 98. A randomized controlled trial in sarcopenic men found no difference in bone mass 87, and a randomized controlled trial in young healthy men found no differences in bone formation and bone resorption markers 132. In part, collagen was tested in combination: in a meta-analysis partly with vitamin D and calcium 19, in a study in children in one group with calcium 79, and in two studies with chicken essence 3839. The optimal form, dose and duration of intake as well as the transferability to men and younger healthy individuals remain open, since the positive findings predominantly concerned postmenopausal women and the participant numbers of the individual studies were small.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ravindran et al. 2026 | systematic review · 7,983 participants | collagen supplements (form not specified); vs. placebo/control (not reported) | bone health: improved |
| 16 Kuhlman et al. 2026 | systematic review | oral collagen peptide supplementation; vs. heterogeneous study designs, some neutral findings | bone turnover markers (P1NP, CTX): improved; bone mineral density (whole body, femoral neck, lumbar spine): improved |
| 18 Brueckheimer et al. 2025 | systematic review | Oral type I hydrolyzed collagen; vs. Control groups of included RCTs | Bone health: unclear |
| 19 Sun et al. 2025 | meta-analysis | Collagen peptides, partly with vitamin D and calcium; vs. Control groups without collagen peptides | Bone mineral density (femoral neck and spine): improved; Bone turnover markers: improved (SMD 0.40-0.58); Bone mineral density with vitamin D and calcium: improved (SMDs 0.40-0.56) |
| 21 Rahman et al. 2024 | systematic review | marine collagen, partly enriched with amino acids | bone damage (tissue engineering): improved |
| 38 Chen et al. 2023 | randomised controlled · 160 participants | Hydrolyzed type II collagen (HC-II) or chicken essence with added HC-II (EC-HC-II); 24 weeks; vs. Glucosamine HCl and placebo, all with resistance training | Bone mass: unclear |
| 39 Chen et al. 2020 | randomised controlled · 160 participants | FlexC-II (type II collagen hydrolysate) or BEC-FlexC-II (with chicken essence); 24 weeks; vs. Glucosamine HCl and placebo, all with resistance training | Left hip bone mass (BEC-FlexC-II, subgroup): improved (P = 0.01; P = 0.049) |
| 79 Martin-Bautista et al. 2011 | randomised controlled · 60 participants | commercial hydrolyzed collagen (Gelatine Royal); 4 months; vs. placebo (G-I), collagen (G-II), collagen+calcium (G-III) | serum IGF-1: improved (p < 0.01); plasma tALP: improved (p < 0.05); serum bALP: improved (p < 0.05) |
Further studies in this area: 87 89 90 95 98 102 118 132 154 181 182 199 207 219 220 232
Collagen, Tendons and Ligaments: Human Studies
In tendons, the cross-sectional area increased more with strength training under collagen peptides than with training alone in a systematic review and several randomized controlled trials, sometimes with vitamin C 229297119122. Tendon stiffness improved in individual randomized controlled trials with collagen peptides plus vitamin C 122126136, while other controlled trials found no difference here 22929799. The findings are based predominantly on small, short studies in healthy, training men.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 8 Bischof et al. 2024 | meta-analysis · 768 participants | Collagen peptide supplements (hydrolyzed collagen); at least 8 weeks (one 3-week trial for maximal strength only; 1 week without exercise for recovery); vs. Control group (RCTs) | Tendon morphology: improved (SMD 0.67, p < 0.01) |
| 12 Buchalski et al. 2026 | systematic review · 257 participants | Collagen supplementation, type not specified; 5-30 g/day, some with vitamin C ≥50 mg; 3-15 weeks, combined with resistance/plyometric training; vs. Placebo | Tendon cross-sectional area: improved (3 of 4 studies reported significantly greater increases); Tendon stiffness/Young's modulus: improved (15-30 g/day) |
| 15 Latini et al. 2026 | systematic review | Hydrolyzed collagen peptides, oral or injectable, some multicomponent; vs. Control groups in randomized trials (placebo/rehabilitation) | Pain, function, analgesic use, imaging outcomes: improved |
| 22 Boldt et al. 2023 | systematic review | Collagen supplementation; vs. Exercise alone | Pain mitigation: improved; Tendon cross-sectional area: improved; Tendon thickness: improved |
| 65 López-Vidriero et al. 2019 | randomised controlled · 72 participants | Progen, oral nutritional supplement; 90-day follow-up; vs. no additional therapy (control group) | Graft maturation (MRI, grades 3 and 4): improved (61.8% vs 38.2%; P < .01) |
| 92 Jerger et al. 2023 | randomised controlled · 50 participants | specific collagen peptides (SCP) vs. placebo; 5 g daily; 14 weeks; vs. placebo plus identical resistance training | patellar tendon cross-sectional area: improved (p < 0.05); tendon stiffness: no difference (p < 0.01) |
| 97 Jerger et al. 2022 | randomised controlled · 40 participants | specific collagen peptides (SCP) vs. placebo; 5 g SCP daily; 14 weeks; vs. placebo (5 g) plus identical resistance training program | Achilles tendon cross-sectional area: improved (+11.0%); tendon stiffness: no difference |
| 99 Balshaw et al. 2023 | randomised controlled · 39 participants | bioactive collagen peptides (CP) vs. placebo; 15 g once daily; 15 weeks; vs. placebo during standardized lower-body resistance training (3x/week) | patellar tendon cross-sectional area: no difference (0.365 ≤ P ≤ 0.877); vastus lateralis aponeurosis area: no difference (0.365 ≤ P ≤ 0.877); patellar tendon stiffness: no difference (0.365 ≤ P ≤ 0.877) |
Further studies in this area: 119 122 126 136 163 186 189 206 223
Collagen, Hair and Nails: Human Studies
For nails, nail color in healthy women improved earlier under collagen peptides than under placebo in a randomized controlled trial 57. In a randomized controlled trial with hydrolyzed collagen and vitamin C, hair appearance improved compared with placebo, with no confirmed difference in hair count 148. Collagen with hyaluronic acid, biotin, and vitamins C and E was associated with less hair loss in a non-randomized study 160. The strength of evidence is moderate, but the findings come from small samples and sometimes short intake periods; it remains open whether the effect is due to collagen alone or to the added substances.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 57 Vleminckx et al. 2024 | randomised controlled · 85 participants | collagen peptide dietary supplement (5 g) vs. placebo (maltodextrin 5 g); 5 g daily; 84 days (assessments at day 28 and 84); vs. placebo (maltodextrin 5 g), both groups used standardized face cream | nail color: improved |
| 148 Reilly et al. 2024 | randomised controlled | Absolute Collagen (AC), hydrolysed collagen with vitamin C; 12 weeks; vs. Placebo | Scalp scaling (trichoscopy): improved (11.0%); Total number of hairs: no difference (27.6%); Clinical grading score for hair healthy appearance: improved (31.9%) |
| 160 Trehan et al. 2024 | controlled · 40 participants | Skin Radiance Collagen (SRC), collagen with antioxidants; 56 days; vs. Placebo | hair fall: improved (28%) |
| 173 Goresh et al. 2025 | cross-sectional study · 171 participants | Oral marine collagen, mostly powder form (80.4%); Use for 4-8 weeks in a subset of users; vs. No control arm; users vs. non-users or by duration of use | Hair/nail improvement: improved (13, 23.2%); Hair/nail improvement with 4-8 weeks use vs. shorter (73.7% versus 26.3%, p=0.033) |
| 180 Bhardwaj et al. 2025 | study · 38 participants | AI-personalized kits with topical serums, shampoos, oral supplements and marine collagen peptides; 24 weeks; vs. no control arm, before-after | hair growth, coverage and thickness: improved (P<0.001 for all); hair shedding: improved (decreased by 37.3% at 12 weeks and 32.4% at 24 weeks); hair texture (scanning electron microscopy): improved |
| 185 Hexsel et al. 2017 | study · 25 participants | bioactive collagen peptides (BCP, VERISOL®); 2.5 g once daily; 24 weeks, then 4-week off-therapy; vs. no control group (open-label) | nail growth rate: improved (increase of 12%); frequency of broken nails: improved (decrease of 42%); global clinical improvement in brittle nails: improved (64%) |
| 211 Biełach-Bazyluk et al. 2026 | review | Oral collagen supplements, mostly collagen peptides, some multi-ingredient formulations; short study durations; manufacturer-funded | hair thickness and strength, nail growth: improved |
| 217 Zaraa et al. 2025 | review | nail dietary supplements, including collagen peptides | clinical appearance, strength and brittleness of nails: improved |
Collagen: Further Outcomes in Studies
Fat mass decreased more with collagen peptides than with placebo in several randomized controlled trials 52556487, but not in others 8085106. Quality of life improved in several controlled studies with collagen peptides or non-denatured type II collagen 46150166. For bioavailability, several controlled studies showed higher plasma amino acid levels after collagen peptides 94116140. Individual controlled studies found improvements in inflammatory markers 118144, while another found no difference here 124. Taken before sleep, collagen peptides reduced nighttime awakening in a randomized controlled trial, but not sleep duration or sleep quality 134. In another, easily fatigued adults felt less tired after sleep 147. The findings apply to the respective forms and preparations studied, mostly collagen peptides as a drink or capsule over several weeks; the transferability to other collagen forms, the role of combination preparations and the long-term clinical relevance of the observed changes remain open.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Ravindran et al. 2026 | systematic review · 7,983 participants | collagen supplements (form not specified); vs. placebo/control (not reported) | oral health and cardiometabolic parameters: unclear |
| 8 Bischof et al. 2024 | meta-analysis · 768 participants | Collagen peptide supplements (hydrolyzed collagen); at least 8 weeks (one 3-week trial for maximal strength only; 1 week without exercise for recovery); vs. Control group (RCTs) | 48 h recovery in reactive strength following exercise-induced muscle damage: improved (SMD 0.43, p = 0.045) |
| 9 Lin et al. 2023 | meta-analysis · 507 participants | Collagen peptides or hydrolyzed collagen; vs. Placebo | Adverse events (OR: 1.66; 95% CI 0.99, 2.78, p = 0.05) |
| 12 Buchalski et al. 2026 | systematic review · 257 participants | Collagen supplementation, type not specified; 5-30 g/day, some with vitamin C ≥50 mg; 3-15 weeks, combined with resistance/plyometric training; vs. Placebo | Eccentric rate of force development/deceleration impulse: improved (One study reported improvements); Jump height: no difference (unaffected) |
| 13 Bassila et al. 2026 | systematic review · 25 participants | Oral hydrolyzed collagen (HC); vs. Placebo or active comparators | Quality of life: unclear (variable improvements) |
| 14 Fan et al. 2026 | systematic review | Glycine-, collagen- or other glycine-containing supplements; vs. Placebo or alpha-lactalbumin as active comparator | Circulating glycine concentrations: improved; Sleep-related outcomes (glycine trials): improved; Polysomnographic awakenings: improved |
| 17 Gupta et al. 2025 | systematic review | Undenatured type II collagen (UC-2); 40 mg daily; short- and mid-term (exact duration not reported); vs. no comparator; review of preclinical and clinical studies | overall quality of life (QoL): improved |
| 20 Inacio et al. 2024 | systematic review | Hydrolyzed collagen or collagen peptides; 50-500 μg/mL | fibroblast stimulation: improved (50-500 μg/mL); bioavailability at lower molecular weight: improved (<3 to 3000 KDa) |
Further studies in this area: 25 32 36 41 43 46 52 55 57 59 62 64 65 68 71 72 73 76 80 82 83 85 87 91 94 95 96 98 100 103 105 106 108 109 110 112 116 118 123 124 129 130 131 133 134 135 138 139 140 142 144 146 147 150 152 155 165 166 168 169 170 171 173 179 181 183 187 191 193 194 195 197 203 206 209 211 213 216 218 224 231 232
4. How Is Collagen Dosed? Preparation, Dose and Duration in Studies
The studies predominantly used oral collagen peptides (hydrolyzed collagen) as a drink, powder or capsule, sometimes over several weeks to months. Non-denatured type II collagen was tested in capsule form, gelatin in individual studies on muscle soreness and recovery. Several studies examined combination preparations, for example with vitamin C, calcium and vitamin D, chicken essence or other active ingredients; the exact doses and intake durations are given in the study cards and tables.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| collagen hydrolysate (CH) | 10 g CH daily | 6 months | 31 |
| Artneo complex containing undenatured chicken type II collagen, one capsule | one capsule once daily | 180 days | 32 |
| Food supplement of collagen hydrolysate | 1200 mg/day | 6 months | 33 |
| Specific collagen peptides (SCP) | 5 g daily | 12 weeks | 34 |
| specific bioactive collagen peptides derived from type I collagen, mean molecular weight 3 kDa | 5 g per day | 12 weeks | 35 |
| Collagen peptide (CP) | 10 g/day | 12 weeks | 36 |
| CollaSel PRO® hydrolyzed collagen type I and III | 10 g/day | 8 weeks | 37 |
| Hydrolyzed type II collagen (HC-II) or chicken essence with added HC-II (EC-HC-II) | — | 24 weeks | 38 |
| FlexC-II (type II collagen hydrolysate) or BEC-FlexC-II (with chicken essence) | — | 24 weeks | 39 |
| Liquid formulation with 10 g collagen hydrolysate (CH-Alpha) | 25 mL liquid containing 10 g collagen hydrolysate daily | 24 weeks | 40 |
| Collagen hydrolysate CH-a (low Pro-Hyp/Hyp-Gly) or CH-b (high Pro-Hyp/Hyp-Gly) | 10 g per day, twice daily | 16 weeks | 41 |
| Liquid nutraceutical with hydrolyzed fish collagen and other active ingredients | — | 90 days | 42 |
| Bioactive collagen peptides (Peptpure®) | 2.5 g/day or 10 g/day | 12 weeks | 43 |
| CollaSel Pro® hydrolyzed collagen peptide, without addons | 10 g daily | 8 weeks | 44 |
| specific bioactive collagen peptides (BCP) | 2.5 g BCP daily orally | 6 months | 45 |
5. Is Collagen Safe? Side Effects in Studies
The studies predominantly report good tolerability of oral collagen peptides without serious adverse events 71331444749505558; non-denatured type II collagen was also well tolerated 86. A systematic review names mild to moderate gastrointestinal complaints as the most common side effect of collagen preparations in osteoarthritis 30; another reports more frequent side effects from individual studies on osteoarthritis and rheumatoid arthritis 24. Individual studies found no significant differences in adverse events compared with placebo 933. Details on the frequency and type of side effects are shown in the table.
| Study | Reported side effects |
|---|---|
| 3 Zahed et al. 2025 | No major adverse events; CMI had higher revision surgery rates |
| 7 Choi et al. 2019 | No reported adverse events |
| 9 Lin et al. 2023 | No significant difference in adverse events (OR 1.66; 95% CI 0.99–2.78; p = 0.05) |
| 13 Bassila et al. 2026 | Generally well tolerated, low incidence of adverse events |
| 17 Gupta et al. 2025 | UC-2 is described as safe |
| 20 Inacio et al. 2024 | no toxicity reported |
| 23 Al-Atif et al. 2022 | no side effects of oral supplements reported |
| 24 Jabbari et al. 2022 | high adverse effects of collagen reported |
| 29 Liu et al. 2018 | No differences versus placebo except for diacerein |
| 30 Van et al. 2012 | mostly mild to moderate gastro-intestinal complaints |
| 31 Benito-Ruiz et al. 2009 | CH is stated to be safe |
| 32 Alekseeva et al. 2024 | good safety profile, no details reported |
6. What Remains Open: Limits of the Evidence
- Many studies were small and short; long-term data on benefits and safety are still pending.
- For several preparations, information on manufacturer funding is missing, which makes it difficult to assess the results.
- The positive findings on bone density come predominantly from postmenopausal women; transferability to men and younger healthy individuals is open.
- Several studies involved combination preparations, so the contribution of collagen alone cannot be determined.
- For non-denatured type II collagen and collagen in skin creams, no controlled studies are available in some areas.
7. Bottom Line: What Is Established About Collagen
Collagen is a structural protein and the most abundant protein in the human body by quantity. Human studies, predominantly with oral collagen peptides (hydrolyzed collagen), show improvements in joint pain and knee osteoarthritis, in skin elasticity and skin moisture, and in tendon cross-sectional area. Fat-free mass also increased more with strength training under collagen peptides than under placebo; muscle protein synthesis, however, did not increase more and remained behind whey protein. For bone density, hair and nails, the findings are mixed and rely on smaller, sometimes short studies, often in postmenopausal women.
Tolerability is described as good in most studies, without serious adverse events. Limitations are that many studies are small and short, several tested combination preparations, and information on manufacturer funding is often missing. The results apply in each case to the form and preparation studied — collagen peptides, gelatin and non-denatured type II collagen are different preparations and not interchangeable.
Frequently Asked Questions
How well has Collagen been studied in humans?
We evaluated 235 human studies on Collagen, including 122 randomised controlled trials and 30 meta-analyses or systematic reviews; the controlled studies include 7,680 participants in total. As of 4 October 2026.
Does Collagen help with joints and joint pain? What the studies show
Does Collagen help with skin and skin elasticity? What the studies show
Does Collagen help with musculature? What the studies show
Does Collagen help with bone density? What the studies show
Does Collagen help with tendons and ligaments? What the studies show
Does Collagen help with hair and nails? What the studies show
Which collagen forms were studied in human studies?
Most studies tested oral collagen peptides (hydrolyzed collagen) as a drink, powder or capsule. Non-denatured type II collagen was studied in capsule form, gelatin in individual studies on muscle soreness and recovery. Collagen-containing foods such as bone broth and collagen in skin creams were less often the subject of controlled studies.
What do the studies show about joints and joint pain?
In joint pain and knee osteoarthritis, several controlled studies and meta-analyses showed improvements in pain and function with oral collagen peptides 69313458. Non-denatured type II collagen also improved mobility in several controlled studies 537386. Individual studies examined combination preparations whose findings cannot be attributed to collagen alone 4254.
How does collagen affect skin and skin elasticity?
For skin and skin elasticity, several controlled studies and meta-analyses showed improvements in skin elasticity and skin moisture after oral collagen peptides 2457134344. The findings are predominantly based on middle-aged women; several studies tested combination preparations, so the contribution of collagen alone remains open there.
Are there studies on muscles?
How safe is collagen?
Sources
- 1Ravindran R, Pizzol D, López-Gil JF, Rahmati M, Boyer L, Fond G et al. · 2026
- 2Pu SY, Huang YL, Pu CM, Kang YN, Hoang KD, Chen KH et al. · 2023
- 3Zahed M, Elmesalmi M, El Menawy Z, Elnaggar N, Elkilany A, Elhanash S et al. · 2025
- 4de Miranda RB, Weimer P, Rossi RC · 2021
- 5Dewi DAR, Arimuko A, Norawati L, Yenny SW, Setiasih NL, Perdiyana A et al. · 2023
- 6Simental-Mendía M, Ortega-Mata D, Acosta-Olivo CA, Simental-Mendía LE, Peña-Martínez VM, Vilchez-Cavazos F · 2025
- 7Oral Collagen Supplementation: A Systematic Review of Dermatological ApplicationsChoi FD, Sung CT, Juhasz ML, Mesinkovsk NA · 2019
- 8
- 9Lin CR, Tsai SHL, Huang KY, Tsai PA, Chou H, Chang SH · 2023
- 10Howell-Morris R · 2020
- 11Inacio PAQ, Gomes YSM, de Aguiar AJN, Lopes-Martins PSL, Aimbire F, Leonardo PS et al. · 2024
- 12Buchalski A, Jeanfavre M, Altorelli C, Leff G · 2026
- 13
- 14Fan Z, Nelson JM, Wallace TC · 2026
- 15Latini L, Porta F, Vitale N, Vreju FA, Filippucci E · 2026
- 16Kuhlman NM, Jagim AR, Blesso C, Jones MT, Chun O, Puglisi M et al. · 2026
- 17Gupta A, Maffulli N · 2025
- 18Brueckheimer PJ, Costa Silva T, Rodrigues L, Zague V, Isaia Filho C · 2025
- 19Sun C, Yang A, Teng F, Xia Y · 2025
- 20Effects of Hydrolyzed Collagen as a Dietary Supplement on Fibroblast Activation: A Systematic ReviewInacio PAQ, Chaluppe FA, Aguiar GF, Coelho CF, Vieira RP · 2024
- 21Rahman DA, Rehmani R, Pirvu DG, Huang M, Puri S, Arcos M · 2024
- 22Boldt KS, Olson BL, Thiele RM · 2023
- 23
- 24Jabbari M, Barati M, Barati M, Khodaei M, Babashahi M, Kalhori A et al. · 2022
- 25Khatri M, Naughton RJ, Clifford T, Harper LD, Corr L · 2021
- 26Barati M, Jabbari M, Nickho H, Esparvarinha M, Javadi Mamaghani A, Majdi H et al. · 2021
- 27Barati M, Barati M, Jabbari M, Navekar R, Farahmand F, Zeinalian R et al. · 2020
- 28García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, Acosta-Olivo CA, Vilchez-Cavazos F, Simental-Mendía LE et al. · 2019
- 29Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ · 2018
- 30Van Vijven JP, Luijsterburg PA, Verhagen AP, van Osch GJ, Kloppenburg M, Bierma-Zeinstra SM · 2012
- 31Benito-Ruiz P, Camacho-Zambrano MM, Carrillo-Arcentales JN, Mestanza-Peralta MA, Vallejo-Flores CA, Vargas-López SV et al. · 2009
- 32Alekseeva LI, Kashevarova NG, Taskina EA, Strebkova EA, Korotkova TA, Sharapova EP et al. · 2024
- 33Bruyère O, Zegels B, Leonori L, Rabenda V, Janssen A, Bourges C et al. · 2012
- 34Schulze C, Schunck M, Zdzieblik D, Oesser S · 2024
- 35Zdzieblik D, Brame J, Oesser S, Gollhofer A, König D, König D · 2021
- 36Bongers CCWG, Ten Haaf DSM, Catoire M, Kersten B, Wouters JA, Eijsvogels TMH et al. · 2020
- 37Demir-Dora D, Tuna S, Kurtoglu ED, Gursoy S, Balci N, Tezman S et al. · 2025
- 38Chen CC, Chang SS, Chang CH, Hu CC, Nakao Y, Yong SM et al. · 2023
- 39Chen C, Chang S, Chang C, Hu C, Nakao Y, Yong SM et al. · 2020
- 40Clark KL, Sebastianelli W, Flechsenhar KR, Aukermann DF, Meza F, Millard RL et al. · 2008
- 41Sugihara F, Inoue N, Venkateswarathirukumara S · 2018
- 42Czajka A, Kania EM, Genovese L, Corbo A, Merone G, Luci C et al. · 2018
- 43Paula-Vieira RHR, Dias SR, Silva-Reis A, Moura-Maia MS, Ramos-Gomes NV, Jesus-Silva K et al. · 2026
- 44Demir-Dora D, Ozsoy U, Yildirim Y, Yilmaz O, Aytac P, Yilmaz B et al. · 2024
- 45Schunck M, Zague V, Oesser S, Proksch E · 2015
- 46
- 47Seong SH, Lee YI, Lee J, Choi S, Kim IA, Suk J et al. · 2024
- 48Devasia S, Joseph JT, P S S, Koizumi S, Clarke L, V T S et al. · 2024
- 49
- 50Kim J, Lee SG, Lee J, Choi S, Suk J, Lee JH et al. · 2022
- 51Miyanaga M, Uchiyama T, Motoyama A, Ochiai N, Ueda O, Ogo M · 2021
- 52Zdzieblik D, Jendricke P, Oesser S, Gollhofer A, König D · 2021
- 53Schön C, Knaub K, Alt W, Durkee S, Saiyed Z, Juturu V · 2022
- 54Aranda CE, Sansó RC, Rico LL, Llorca CS, Turpin JAP · 2025
- 55Tak YJ, Kim YJ, Lee JG, Yi YH, Cho YH, Kang GH et al. · 2019
- 56Žmitek K, Žmitek J, Hristov H, Rogl Butina M, Keršmanc P, Pogačnik T · 2024
- 57Vleminckx S, Virgilio N, Asserin J, Prawitt J, Silva CIF · 2024
- 58Park SY, Lee SH, Kim HT, Park HJ, Kim DU, Kim SU et al. · 2025
- 59Salinas-Camargo JC, Marín-Pagán C, Álvarez-Gil RV, Martínez-Noguera FJ, Cabrera-Cabrera M, Llabrés-Laguarda JM et al. · 2025
- 60Carrillo-Norte JA, García-Mir B, Quintana L, Buracchio B, Guerrero-Bonmatty R · 2024
- 61Wang Y, Zhu W, Luo W, Ma Y, Zhou Y · 2025
- 62Jendricke P, Centner C, Zdzieblik D, Gollhofer A, König D, König D · 2019
- 63Möller I, Martínez K, Terradillos-Guillén A, Costa-Larrión E, Martínez-Puig D, Velasco-Álvarez J · 2026
- 64Park J, Kim M, Shin H, Ahn H, Park YK · 2023
- 65López-Vidriero E, Olivé-Vilas R, López-Capapé D, Varela-Sende L, López-Vidriero R, Til-Pérez L · 2019
- 66Bolke L, Schlippe G, Gerß J, Voss W · 2019
- 67Lee E, Ahn DK, Kim JH, Lee S, Kim HJ, Lee HK et al. · 2025
- 68Mazurov VI, Belyaeva IB, Trofimov EA, Itskovich IE, Burulev AL · 2023
- 69Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S · 2014
- 70Yuenyongviwat V, Anusitviwat C, Tuntarattanapong P, Hongnaparak T, Iamthanaporn K · 2025
- 71Alipoor E, Jazayeri S, Dahmardehei M, Salehi S, Yaseri M, Emami MR et al. · 2023
- 72López-Yoldi M, Riezu-Boj JI, Abete I, Ibero-Baraibar I, Aranaz P, González-Salazar I et al. · 2024
- 73Shiojima Y, Takahashi M, Takahashi R, Maruyama K, Moriyama H, Bagchi D et al. · 2023
- 74Kim DU, Chung HC, Choi J, Sakai Y, Lee BY · 2018
- 75Naumov AV, Unkovskiy AV, Khovasova NO, Fokeev DK, Kolesnikova AV · 2025
- 76Farì G, Santagati D, Pignatelli G, Scacco V, Renna D, Cascarano G et al. · 2022
- 77Collagen Supplement Improves Skin Attributes in Healthy Adults· 2021
- 78Laing S, Bielfeldt S, Ehrenberg C, Wilhelm KP · 2020
- 79Martin-Bautista E, Martin-Matillas M, Martin-Lagos JA, Miranda-Leon MT, Muñoz-Torres M, Ruiz-Requena E et al. · 2011
- 80Jendricke P, Kohl J, Centner C, Gollhofer A, König D · 2020
- 81Kirmse M, Oertzen-Hagemann V, de Marées M, Bloch W, Platen P · 2019
- 82
- 83
- 84Guadanhim LRS, Miot HA, Soares JLM, Silva SAM, Leonardi GR, Lopes RD et al. · 2023
- 85Bischof K, Stafilidis S, Bundschuh L, Oesser S, Baca A, König D · 2023
- 86Lugo JP, Saiyed ZM, Lau FC, Molina JP, Pakdaman MN, Shamie AN et al. · 2013
- 87Zdzieblik D, Oesser S, Baumstark MW, Gollhofer A, König D · 2015
- 88Evaluation of the Efficacy of a Hydrolyzed Collagen Supplement for Improving Skin Moisturization, Smoothness, and WrinklesBianchi FM, Angelinetta C, Rizzi G, Praticò A, Villa R · 2022
- 89Lampropoulou-Adamidou K, Karlafti E, Argyrou C, Makris K, Trovas G, Dontas IA et al. · 2022
- 90Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopeniaArgyrou C, Karlafti E, Lampropoulou-Adamidou K, Tournis S, Makris K, Trovas G et al. · 2020
- 91Alekseeva LI, Kashevarova NG, Taskina EA, Strebkova EA, Korotkova TA, Sharapova EP et al. · 2025
- 92Jerger S, Centner C, Lauber B, Seynnes O, Friedrich T, Lolli D et al. · 2023
- 93Tassinari E, Minerba A, Basile T, Bucciarelli A, Traina F, Grigolo B et al. · 2025
- 94Aussieker T, Kaiser J, Hendriks FK, Janssen TAH, Senden JM, VAN Kranenburg JMX et al. · 2025
- 95Seyhan S, Jourkesh M, Salatin A, Acar G, Bilici MF, Girginer FG et al. · 2026
- 96de Abreu de Vasconcellos SJ, Souza Dos Santos Marques R, Gomes Magalhães de Melo E, Silva de Almeida C, de Almeida Góes Silva JV, de Almeida Souza LM et al. · 2023
- 97Jerger S, Centner C, Lauber B, Seynnes O, Sohnius T, Jendricke P et al. · 2022
- 98Monsegue AP, Thudium CS, Wilms EJC, Mohren RJC, Boonen B, Geurts JAP et al. · 2026
- 99Balshaw TG, Funnell MP, McDermott EJ, Maden-Wilkinson TM, Massey GJ, Abela S et al. · 2023
- 100Jockel-Schneider Y, Stoelzel P, Hess J, Haubitz I, Fickl S, Schlagenhauf U · 2022
- 101
- 102Elam ML, Johnson SA, Hooshmand S, Feresin RG, Payton ME, Gu J et al. · 2015
- 103Giglio BM, Schincaglia RM, da Silva AS, Fazani ICS, Monteiro PA, Mota JF et al. · 2019
- 104
- 105Genç AS, Yılmaz AK, Anıl B, Korkmaz Salkılıç E, Akdemir E, Güzel B et al. · 2025
- 106Jerger S, Jendricke P, Centner C, Bischof K, Kohl J, Keller S et al. · 2023
- 107Genç AS, Yılmaz AK, Anıl B, Korkmaz Salkılıç E, Akdemir E, Sancaklı A et al. · 2025
- 108Bagheri Miyab K, Alipoor E, Vaghardoost R, Saberi Isfeedvajani M, Yaseri M, Djafarian K et al. · 2020
- 109Virgilio N, Schön C, Steiner N, Schlageter V, Wilhelm M, Silva CI et al. · 2026
- 110
- 111Oliviero F, Ramonda R, Hoxha A, Scanu A, Galozzi P, Favero M et al. · 2020
- 112Effects of Blood Flow Restriction Training with Protein Supplementation on Muscle Mass And Strength in Older MenCentner C, Zdzieblik D, Roberts L, Gollhofer A, König D · 2019
- 113McAlindon TE, Nuite M, Krishnan N, Ruthazer R, Price LL, Burstein D et al. · 2011
- 114Jerger S, Nielsen JL, Centner C, Mathiesen J, Suetta C, Oesser S et al. · 2026
- 115Wageh M, Fortino SA, McGlory C, Kumbhare D, Phillips SM, Parise G · 2021
- 116Kirmse M, Lottmann TM, Volk NR, DE Marées M, Holwerda AM, VAN Loon LJC et al. · 2024
- 117Oertzen-Hagemann V, Kirmse M, Eggers B, Pfeiffer K, Marcus K, de Marées M et al. · 2019
- 118Kuhlman NM, Jagim AR, Blesso CN, Puglisi MJ, Chun OK, Jones MT et al. · 2026
- 119
- 120Jacinto JL, Nunes JP, Gorissen SHM, Capel DMG, Bernardes AG, Ribeiro AS et al. · 2022
- 121Petersen Vitello Kalil CL, Campos V, Cignachi S, Favaro Izidoro J, Prieto Herman Reinehr C, Chaves C · 2018
- 122Nulty CD, Phelan K, Erskine RM · 2025
- 123Tafuri A, Panunzio A, Tricarico M, Tricarico EM, Mazzarella CR · 2025
- 124Taylor G, Leonard A, Tang JCY, Dunn R, Fraser WD, Virgilio N et al. · 2023
- 125Kuwaba K, Kusubata M, Taga Y, Igarashi H, Nakazato K, Mizuno K · 2023
- 126Lee J, Bridge JE, Clark DR, Stewart CE, Erskine RM · 2023
- 127Saiyed Z, Durkee S, Bowman J, Juturu V · 2021
- 128Paulus MC, Kouw IWK, Boelens YFN, Hermans AJH, Strookappe B, van Zanten ARH · 2025
- 129Reynolds KM, Hansell EJ, Thorley J, Funnell MP, Thackray AE, Stensel DJ et al. · 2025
- 130Louis MJ, Balakrishnan A, Joseph A, Shanmughan P, Maliakel B, Illathu Madhavamenon K · 2023
- 131Walrand S, Chiotelli E, Noirt F, Mwewa S, Lassel T · 2008
- 132Hilkens L, Boerboom M, van Schijndel N, Bons J, van Loon LJC, van Dijk JW · 2023
- 133
- 134Thomas C, Kingshott RN, Allott KM, Tang JCY, Dunn R, Fraser WD et al. · 2024
- 135Correia F, Gouveia S, Felino AC, Faria-Almeida R, Pozza DH · 2024
- 136Lee J, Robshaw DC, Erskine RM · 2025
- 137Oikawa SY, Macinnis MJ, Tripp TR, McGlory C, Baker SK, Phillips SM · 2020
- 138Lee J, Tang JCY, Dutton J, Dunn R, Fraser WD, Enright K et al. · 2024
- 139Duarte GMF, de Freitas KV, Marini ACB, Giglio BM, Fernandes RC, Lobo PCB et al. · 2022
- 140Skov K, Oxfeldt M, Thøgersen R, Hansen M, Bertram HC · 2019
- 141Brook MS, Scaife P, Bass JJ, Cegielski J, Watanabe S, Wilkinson DJ et al. · 2021
- 142Proksch E, Schunck M, Zdzieblik D, Oesser S · 2026
- 143Graham RR, Salgado BE, Guerrero E, Carrasco AP, D'Lugos AC · 2026
- 144Carrillo-Norte JA, Gervasini-Rodríguez G, Santiago-Triviño MÁ, García-López V, Guerrero-Bonmatty R · 2025
- 145González-Rodríguez Y, La Nuez-García MA, Jiménez M, Villar-Suárez V, Casado-Santos A · 2025
- 146Virgilio N, Schoen C, van der Steen B, Kleinnijenhuis AJ, van Holthoon FL, Vleminckx S et al. · 2025
- 147Kuwaba K, Kusubata M, Saito M, Mizuno K · 2024
- 148Reilly DM, Kynaston L, Naseem S, Proudman E, Laceby D · 2024
- 149Santana ÉTN, da Cunha Machado S, Brandão Lima VN, DeSantana Filho VJ, Dos Santos Maciel LY, de Farias Neto JP et al. · 2023
- 150Kviatkovsky SA, Hickner RC, Cabre HE, Small SD, Ormsbee MJ · 2023
- 151Centner C, Jerger S, Mallard A, Herrmann A, Varfolomeeva E, Gollhofer S et al. · 2022
- 152
- 153Zdzieblik D, Oesser S, Gollhofer A, König D · 2017
- 154[Postmenopausal osteoporosis. Treatment with calcitonin and a diet rich in collagen proteins]Adam M, Spacek P, Hulejová H, Galiánová A, Blahos J · 1996
- 155Luijpers CLH, Nuijten MAH, Groenhuijzen EJ, van Hogezand LL, Monpellier VM, Eijsvogels TMH et al. · 2024
- 156Maia Campos PMBG, Melo MO, Siqueira César FC · 2019
- 157Jung K, Kim SH, Joo KM, Lim SH, Shin JH, Roh J et al. · 2021
- 158Thomas DT, Prabhakar AJ, Eapen C, Patel VD, Palaniswamy V, Dsouza MC et al. · 2023
- 159Yoon HS, Cho HH, Cho S, Lee SR, Shin MH, Chung JH · 2014
- 160Trehan A, Anand R, Chaudhary G, Garg H, Verma MK · 2024
- 161Motwani MS, Khan K, Pai A, Joshi R · 2020
- 162Wageh M, Fortino SA, Pontello R, Maklad A, McGlory C, Kumbhare D et al. · 2024
- 163Praet SFE, Purdam CR, Welvaert M, Vlahovich N, Lovell G, Burke LM et al. · 2019
- 164Baba M, Suzaki E, Taira K, Ito Y, Kachi H, Okada A · 2020
- 165Hays NP, Kim H, Wells AM, Kajkenova O, Evans WJ · 2009
- 166Sadigursky D, Magnavita VFS, Sá CKC, Monteiro HS, Braghiroli OFM, Matos MAA · 2022
- 167Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M et al. · 2009
- 168Nulty CD, Walton J, Erskine RM · 2025
- 169Frantzi M, Keller F, Latosinska A, Beige J, Mebazaa A, Caillard A et al. · 2026
- 170Ashour AM, Wali SM, Alorfi NM, Alshehri FS, Alhazmi BA, Aldurdunji MM et al. · 2026
- 171
- 172Puigdellívol Grifell J, Comellas Berenguer C, Steinbacher G, Kranjcec T, Álvarez Díaz P, López Pujol A et al. · 2024
- 173Goresh HK, Almarwani SH, Alhomidani F, Alharbi FA, Alharbi JS, Alkatheri N et al. · 2025
- 174Gibson R, Krug L, Ramsey DL, Safaei A, Aspley S · 2024
- 175Puigdellivol J, Comellas Berenger C, Pérez Fernández MÁ, Cowalinsky Millán JM, Carreras Vidal C, Gil Gil I et al. · 2019
- 176Shavlovskaya OA, Romanov ID, Bokova IA · 2025
- 177Fernández-Jaén TF, García de Vega C, Sáiz P, Björk P, Rodríguez-Iñigo E, López-Alcorocho JM et al. · 2023
- 178
- 179Abrahams M, O'Grady R, Prawitt J · 2022
- 180Bhardwaj V, Rodgers N, Harth O, Harth Y · 2025
- 181Nilsson MI, Xhuti D, de Maat NM, Hettinga BP, Tarnopolsky MA · 2024
- 182Zdzieblik D, Oesser S, König D · 2021
- 183Koizumi S, Inoue N, Sugihara F, Igase M · 2019
- 184Lee YI, Lee SG, Kim J, Choi S, Jung I, Lee JH · 2021
- 185Hexsel D, Zague V, Schunck M, Siega C, Camozzato FO, Oesser S · 2017
- 186Latini L, Porta F, Maccarrone V, Zompa D, Cipolletta E, Mirza RM et al. · 2024
- 187Tafuri A, Panunzio A, Mazzarella CR, Tricarico M, Tricarico EM · 2025
- 188Samadi A, Movaffaghi M, Kazemi F, Yazdanparast T, Ahmad Nasrollahi S, Firooz A · 2023
- 189Porta F, Filippucci E, Barni X, Dinescu SC, Vreju FA · 2025
- 190Dähnhardt D, Dähnhardt-Pfeiffer S, Segger D, Poeggeler B, Lemmnitz G · 2024
- 191Nulty CD, Tang JCY, Dutton J, Dunn R, Fraser WD, Enright K et al. · 2024
- 192Mejía-Calvo I, López-Juárez LE, Vázquez-Leyva S, López-Morales CA, Montoya-Escutia D, Merlos Rivera PG et al. · 2021
- 193Ye X, Jin O, Zheng A, Lv N, Guo J, Xiang J et al. · 2026
- 194He L, Liu R, Chen L, Liu J, Wang M, Yu J et al. · 2025
- 195Mina IK, Iglesias-Martinez LF, Ley M, Fillinger L, Perco P, Siwy J et al. · 2025
- 196Egner P, Pavlačková J, Sedlaříková J, Matošková L, Mokrejš P, Janalíková M · 2025
- 197Dakhovnik A, Mantovani M, Knufinke M, Brügger V, Pramono I, Statzer C et al. · 2025
- 198Chae M, Moon CY, Lim SH, Yamashita Y, Yamada H, Ide M et al. · 2023
- 199Wauquier F, Daneault A, Granel H, Prawitt J, Fabien Soulé V, Berger J et al. · 2019
- 200Addor FAS, Cotta Vieira J, Abreu Melo CS · 2018
- 201Yazaki M, Ito Y, Yamada M, Goulas S, Teramoto S, Nakaya MA et al. · 2017
- 202Sawamura S, Jinnin M, Kajihara I, Makino K, Aoi J, Ichihara A et al. · 2017
- 203Yamamoto S, Deguchi K, Onuma M, Numata N, Sakai Y · 2016
- 204McAlindon T, Bartnik E, S Ried J, Teichert L, Herrmann M, Flechsenhar K · 2016
- 205Gürtler AL, Sirois JP, Heckenbach IJ, Scherf-Clavel O, Scheibye-Knudsen M, Heinz A · 2026
- 206
- 207Zulfiqar Z, Kot J, Lee K, Leja W, Latalska K, Zjawiony J et al. · 2026
- 208Kurtz JA, Singleton KM, Vasenina E, Jäger R, Gonzalez D, Schwarz A et al. · 2026
- 209Mishra MK, Mohanta GP, Ahmad R, Goyal A, Tiwari A · 2026
- 210Lei D, Zhang G, Guo T, Zhang L, Man MQ · 2026
- 211Biełach-Bazyluk A, Jurga M, Flisiak I, Zbroch E · 2026
- 212Prabhoo R, Patel S, Sardar I, Jangid S, Thirupathy RV, Roy R · 2026
- 213Aragona ES, Cavallini M, Christopoulos G, Mantoan M, Raichi M · 2026
- 214Ivaskiene T, Viskelis J, Streimikyte P, Savickaitė M, Mobasheri A, Kaspute G · 2025
- 215Wang Y, Cao Z, Gao Y, Shao P, Gao S, Dong M et al. · 2025
- 216Olabiyi AA, de Castro Braz LE · 2025
- 217Zaraa I, Richert B · 2025
- 218Rahman A, Rehmani R, Pirvu DG, Huang SM, Puri S, Arcos M · 2024
- 219Al Hajj W, Salla M, Krayem M, Khaled S, Hassan HF, El Khatib S · 2024
- 220Campos LD, Santos Junior VA, Pimentel JD, Carregã GLF, Cazarin CBB · 2023
- 221Larder CE, Iskandar MM, Kubow S · 2023
- 222Morgado-Carrasco D, Gil-Lianes J, Jourdain E, Piquero-Casals J · 2023
- 223Kviatkovsky SA, Hickner RC, Ormsbee MJ · 2022
- 224Shavlovskaya OA, Gromova OA, Torshin IY · 2022
- 225Muzumdar S, Ferenczi K · 2021
- 226
- 227Apostu D, Lucaciu O, Mester A, Oltean-Dan D, Baciut M, Baciut G et al. · 2019
- 228Vaishya R, Agarwal AK, Shah A, Vijay V, Vaish A · 2018
- 229
- 230Ragle RL, Sawitzke AD · 2012
- 231
- 232Moskowitz RW · 2000
- 233
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.